How many insider declarations has Greven, Marianne filed?

Greven, Marianne has filed 2 public insider declarations with SEDI.

What is Greven, Marianne's role?

Greven, Marianne's reported role is not specified by the regulator across the filings.

Which companies does Greven, Marianne report trades for?

Greven, Marianne reports trades for Kane Biotech Inc..

← Executives ★ Sign in to follow

GM

Greven, Marianne

OFFICERF

·SEDI

Kane Biotech Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the complete record of transactions filed by Greven, Marianne. Officer active across 1 company, notably Kane Biotech Inc.. Cumulatively, 2 filings have been published. Activity tracked since 28 May 2026. The latest transaction was filed on 28 May 2026 (50 - Grant of options). Regulator: SEDI. The full history is free.

Companies and markets linked to Greven, Marianne

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Kane Biotech Inc. (CA)

Declarations2 total

◇

Greven, Marianne

4 - Director of IssuerExecutives28 May 2026Kane Biotech Inc.

CA$25,00030SEDI ↗

500,000 shares@ CA$0.050.41% mcap100.0% of flowOptionsTSXSEDI:4746382

●

Greven, Marianne

4 - Director of IssuerExecutives25 Jun 2025Kane Biotech Inc.

0SEDI ↗

OptionsTSXSEDI:4746327

2 of 2 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

GM

Greven, Marianne

OFFICERF

·SEDI

Kane Biotech Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the complete record of transactions filed by Greven, Marianne. Officer active across 1 company, notably Kane Biotech Inc.. Cumulatively, 2 filings have been published. Activity tracked since 28 May 2026. The latest transaction was filed on 28 May 2026 (50 - Grant of options). Regulator: SEDI. The full history is free.